# Francesco Raspagliesi

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/francesco-raspagliesi/

## Facts

| Field | Value |
| --- | --- |
| Citations | 22,377 |
| Field | Endometrial and Cervical Cancer Treatments |
| h-index | 70 |
| i10-index | 339 |
| Last Known Institution | University of Milan |
| OpenAlex ID | https://openalex.org/A5000568505 |
| ORCID iD | https://orcid.org/0000-0001-8953-1657 |
| Works | 738 |

## Researcher papers

- [Systematic Pelvic Lymphadenectomy vs No Lymphadenectomy in Early-Stage Endometrial Carcinoma: Randomized Clinical Trial](https://scholariq.org/papers/systematic-pelvic-lymphadenectomy-vs-no-lymphadenectomy-in-early-stage/)
- [Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer](https://scholariq.org/papers/dostarlimab-for-primary-advanced-or-recurrent-endometrial-cancer/)
- [A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms](https://scholariq.org/papers/a-randomized-trial-of-lymphadenectomy-in-patients-with-advanced-ovarian/)
- [The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer](https://scholariq.org/papers/the-european-society-of-gynaecological-oncology-european-society-for-3/)
- [Systematic Aortic and Pelvic Lymphadenectomy Versus Resection of Bulky Nodes Only in Optimally Debulked Advanced Ovarian Cancer: A Randomized Clinical Trial](https://scholariq.org/papers/systematic-aortic-and-pelvic-lymphadenectomy-versus-resection-of-bulky-nodes/)
- [Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study](https://scholariq.org/papers/efficacy-and-safety-of-tisotumab-vedotin-in-previously-treated-recurrent-or/)
- [The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer](https://scholariq.org/papers/the-european-society-of-gynaecological-oncology-european-society-for-2/)
- [SUCCOR study: an international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 cervical cancer](https://scholariq.org/papers/succor-study-an-international-european-cohort-observational-study-comparing/)
- [The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer](https://scholariq.org/papers/the-european-society-of-gynaecological-oncology-european-society-for/)
- [Uterine serous carcinoma](https://scholariq.org/papers/uterine-serous-carcinoma/)

## Researcher topics

- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Cervical Cancer and HPV Research](https://scholariq.org/topics/cervical-cancer-and-hpv-research/)
- [Uterine Myomas and Treatments](https://scholariq.org/topics/uterine-myomas-and-treatments-2/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)

## Researcher university

- [University of Milan](https://scholariq.org/institutions/university-of-milan/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.